Use of Semiautomatic Treatment Advice to Improve Compliance with Infectious Diseases Society of America Guidelines for Treatment of Intravascular Catheter-Related Infection: A Before-After Study

Rijnders, Bart J.A.; Vandecasteele, Stefaan J.; Van Wijngaerden, Eric; De Munter, Paul; Peetermans, Willy E.
October 2003
Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, p980
Academic Journal
Describes the use of semiautomatic treatment advice to improve compliance with the Infectious Diseases Society of America guidelines for the treatment of catheter-related bloodstream infection (CRBSI) in the U.S. Accounts on the symptoms of sepsis; Management of intravascular catheter-related infections; Increase of the use of antibiotics to treat CRBSI.


Related Articles

  • Antibiotic proves effective in trials.  // Dermatology Times;Jan1999, Vol. 20 Issue 1, p3 

    Reports on a study presented at the 1998 Meeting of Infectious Diseases Society of America in Denver, Colorado showing the effectiveness of pexiganan acetate, a topical antibiotic and an antimicrobial peptide of animal origin, against clinical isolates of gram-negative and gram-positive pathogens.

  • Globe-trotting Bacteria. Voelker, Rebecca // JAMA: Journal of the American Medical Association;12/22/99, Vol. 282 Issue 24, p2291 

    Reports on findings of a drug capable of fighting disease-causing bacteria that have become resistant to existing antibiotics by the Infectious Diseases Society of America. Linezolid's effectiveness against resistant strains of bacteria; The need for good infection control practices.

  • Guidelines for the Management of Intravascular Catheter-Related Infections. Mermel, Leonard A.; Fart, Barry M.; Sherertz, Robert J.; Raad, Issam I.; O'Grady, Naomi; Harris, JoAnn S.; Craven, Donald E. // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1249 

    Presents guidelines from the Infectious Diseases Society of America, the American College of Critical Care Medicine and the Society for Healthcare Epidemiology of America for the management of intravascular catheter-related infections. Epidemiology and pathogenesis of these infections; Different...

  • Structural Development of Biological Response Modifiers Based on Retinoids and Thalidomide. Yuichi Hashimoto // Mini Reviews in Medicinal Chemistry;Dec2002, Vol. 2 Issue 6, p543 

    The full-scale commercial appearance of antibiotics in the 1950's caused a shift of the nature of our lethal diseases from infectious / acute to non-infectious / chronic. In this situation, biological response modifiers (BRM's), which are not based on selective toxicity, are expected to be...

  • IDSA calls for 10 new antibiotics in 10 years.  // Infectious Disease News;Dec2009, Vol. 22 Issue 12, p3 

    The article reports on the appeal of the Infectious Diseases Society of America (IDSA) to the administration of U.S. President Barack Obama and the European Union to help realize the goal of bringing to market ten antibiotics through 2019.

  • Empirical Antibiotic Choice for the Seriously Ill Patient: Are Minimization of Selection of Resistant Organisms and Maximization of Individual Outcome Mutually Exclusive? Paterson, David L.; Rice, Louis B. // Clinical Infectious Diseases;4/15/2003, Vol. 36 Issue 8, p1006 

    Reviews strategies that are practiced to reduce the hazards of broad empirical antibiotic therapy, while aiming to ensure that empirical therapy is adequate. Discontinuation or streamlining of empirical therapy when culture results are available; Condition for high mortality related to serious...

  • Study: Antibiotic resistance growing.  // Long Island Business News (7/1993 to 5/2009);12/18/98, Vol. 45 Issue 51, p1B 

    Summarizes findings of the study, entitled `A Local Evaluation of Resistance Trends' at North Shore University Hospital which indicates that community acquired infections are resistant to commonly prescribed antibiotics. Director of microbiology and molecular diagnostics for the North...

  • Use this antibiotic once a day for stubborn infections. Cerrato, Paul L. // RN;Sep97, Vol. 60 Issue 9, p74 

    Reports that antibiotic levofloxacin is used for the treatment of infections. Identification of infections treated by levofloxacin; Advantage of the levofloxacin.

  • Editorial Response: Impact of Infectious Diseases Specialists.  // Clinical Infectious Diseases;7/1/99, Vol. 29 Issue 1, p67 

    Comments on the article about the antibiotic-use guidelines for infectious diseases. Benefits of correct antibiotic use in reducing mortality; Impact of infectious disease specialists (IDS) decisions regarding empirical antibiotic therapy; How to ensure that IDS expertise will benefit as many...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics